NDC11 50228055730
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50228-0557-30 | 50228-0557 |
| 50228-557-30 | 50228-557 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| brivaracetam | BRIVARACETAM | ScieGen Pharmaceuticals, Inc. | bdbb6756-654c-46f1-a85c-7d5d1a89685a | 2026-07-23 | Warnings, Adverse reactions | 50228-557-30 50228-557 50228055730 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.